Using CRISPR to launch a dual attack on COVID-19, health care disparities in DelawareJul. 29, 2020ChristianaCare researchers are evaluating the CRISPR-based SHERLOCK COVID-19 test to ensure greater accessibility of breakthroughs to underserved populations. The post Using CRISPR to launch a dual attack on COVID-19, health care disparities in Delaware appeared first on ChristianaCare News.
New CRISPR advance delivers a one-two punch to lung cancer cellsJul. 6, 2020A mutation unique to certain cancer tumors is a potential homing beacon for safely deploying CRISPR gene editing enzymes to disarm DNA that makes cancer cells resistant to treatment, while ignoring the gene in normal cells where it’s critical to healthy function. The post New CRISPR advance delivers a one-two punch to lung cancer cells appeared first on ChristianaCare News.
Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technologyMar. 3, 2020As laboratory breakthroughs using CRISPR gene editing technology advance from bench to bedside – including a lung cancer clinical trial from the Gene Editing Institute at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute – federal policies and guidelines to ensure safe, effective therapies have lagged behind. But last month they took a major […] The post Federal guidelines will speed bench-to-bedside research and advance clinical trials using gene editing technology appeared first on ChristianaCare News.
New tool for rapid analysis of CRISPR reveals frequent, unintended DNA changesDec. 10, 2019Amidst rising hopes for using CRISPR gene editing tools to repair deadly mutations linked to conditions like cystic fibrosis and sickle cell disease, a new study in the Nature journal Communications Biology describes an innovation that could accelerate this work by rapidly revealing unintended and potentially harmful changes introduced by the gene editing process. “We’ve […] The post New tool for rapid analysis of CRISPR reveals frequent, unintended DNA changes appeared first on ChristianaCare News.
Delaware Bio Breakfast features two Christiana Care gene editing scientistsJul. 29, 2019Scientists from Christiana Care’s Gene Editing Institute discussed their breakthrough CRISPR gene editing research at the Delaware BioBreakfast at the John H. Ammon Medical Education Center at Christiana Hospital on July 26. Brett Sansbury, a third-year doctoral student at the University of Delaware, spoke about a CRISPR gene-editing tool she discovered to successfully engineer […] The post Delaware Bio Breakfast features two Christiana Care gene editing scientists appeared first on ChristianaCare News.
Bringing CRISPR technology to minority communities: Eric Kmiec heads expert panelJun. 19, 2019While the extraordinary potential of CRISPR gene editing technology is now being realized, it is not yet reaching minority communities. That was the take-away message of a panel discussion on how genome editing can impact unmet medical needs moderated by Eric Kmiec, Ph.D., director of Christiana Care’s Gene Editing Institute, at the 2019 BIO International […] The post Bringing CRISPR technology to minority communities: Eric Kmiec heads expert panel appeared first on ChristianaCare News.
Missed Mini-Medical School? Catch up with classes on YouTube!May. 8, 2019If you have a passion for health care or just want to get a taste of what doctors learn in medical school, check out our free videos from Mini Medical School 2019. This popular six-week course of free lectures, led by partners Christiana Care and the Delaware Academy of Medicine/Delaware Public Health Association, attracted 200 […] The post Missed Mini-Medical School? Catch up with classes on YouTube! appeared first on ChristianaCare News.
Gene Editing Institute takes next step to advance lung cancer trial using CRISPRMay. 2, 2019In a historic next step in the development of a clinical trial for lung cancer patients using CRISPR gene editing technology, Christiana Care’s Gene Editing Institute is preparing its preliminary investigational new drug application (IND) with the U.S. Food and Drug Administration. This marks the first time Christiana Care’s Gene Editing Institute is developing its […] The post Gene Editing Institute takes next step to advance lung cancer trial using CRISPR appeared first on ChristianaCare News.
The Gene Editing Institute licenses CRISPR technology to NovellusDx to drive next-generation cancer careApr. 18, 2019Scientists at Christiana Care Health System’s Gene Editing Institute and NovellusDx, an Israeli biotechnology company, have deployed a breakthrough CRISPR gene-editing tool to successfully engineer multiple edits simultaneously to fragments of DNA extracted from a human cell, according to a new study published today in The CRISPR Journal. The tool can rapidly reproduce, in a […] The post The Gene Editing Institute licenses CRISPR technology to NovellusDx to drive next-generation cancer care appeared first on ChristianaCare News.